1242PA PHASE I STUDY OF THE MEK1/2 INHIBITOR SELUMETINIB IN...

Annals of Oncology 2014 / 09 Vol. 25; Iss. suppl_4

1242PA PHASE I STUDY OF THE MEK1/2 INHIBITOR SELUMETINIB IN COMBINATION WITH FIRST-LINE CHEMOTHERAPY REGIMENS FOR NSCLC

Dean, E., Steele, N., Arkenau, H., Blackhall, F., Haris, N.M., Lindsay, C., Saggese, M., Califano, R., Greystoke, A., Voskoboynik, M., Ghiorghiu, D., Dymond, A., Smith, I., Plummer, R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu349.21
Date:
September, 2014
File:
PDF, 66 KB
english, 2014
Conversion to is in progress
Conversion to is failed